Adial Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADIL and other ETFs, options, and stocks.

About ADIL

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. 

CEO
Cary J. Claiborne
CEOCary J. Claiborne
Employees
7
Employees7
Headquarters
Glen Allen, Virginia
HeadquartersGlen Allen, Virginia
Founded
2010
Founded2010
Employees
7
Employees7

ADIL Key Statistics

Market cap
2.01M
Market cap2.01M
Price-Earnings ratio
-0.11
Price-Earnings ratio-0.11
Dividend yield
Dividend yield
Average volume
255.31K
Average volume255.31K
High today
$1.99
High today$1.99
Low today
$1.77
Low today$1.77
Open price
$1.97
Open price$1.97
Volume
99.16K
Volume99.16K
52 Week high
$30.25
52 Week high$30.25
52 Week low
$1.77
52 Week low$1.77

Stock Snapshot

With a market cap of 2.01M, Adial Pharmaceuticals(ADIL) trades at $1.90. The stock has a price-to-earnings ratio of -0.11.

On 2026-03-06, Adial Pharmaceuticals(ADIL) stock traded between a low of $1.77 and a high of $1.99. Shares are currently priced at $1.90, which is +7.5% above the low and -4.5% below the high.

The Adial Pharmaceuticals(ADIL)'s current trading volume is 99.16K, compared to an average daily volume of 255.31K.

In the last year, Adial Pharmaceuticals(ADIL) shares hit a 52-week high of $30.25 and a 52-week low of $1.77.

In the last year, Adial Pharmaceuticals(ADIL) shares hit a 52-week high of $30.25 and a 52-week low of $1.77.

ADIL News

TipRanks 3d
Adial Pharmaceuticals enters collaboration framework agreement with Molteni

Adial Pharmaceuticals (ADIL) announced it has entered into a collaboration framework agreement with Molteni Farmaceutici for a proposed exclusive partnership co...

Benzinga 4d
EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million

Adial Pharmaceuticals Inc. (NASDAQ:ADIL) on Tuesday entered into a collaboration framework agreement with Molteni Farmaceutici for a proposed exclusive partners...

EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million

People also own

Based on the portfolios of people who own ADIL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.